Structural Health Monitoring Market Size, Share, Industry, Forecast and outlook (2023-2030)

The market is segmented by treatment type (monotherapy vs. combination therapy), drug class (cephalosporins, aminoglycosides, etc.), route of administration (oral, intravenous, etc.), and distribution channel (hospital pharmacies, online pharmacies, etc.).

The market is driven by several factors, including rising incidences of hospital-acquired infections, increasing drug resistance, and growing awareness of advanced treatment options. Additionally, the rapid development of healthcare infrastructure in Asia Pacific is contributing to the market's expansion.

The global market for Pseudomonas aeruginosa infection treatment is expected to reach $2.5 billion by 2030, growing at a CAGR of 6.6% from 2023 to 2030.

The Asia Pacific region is expected to have the fastest growth due to factors like increasing awareness, growing healthcare infrastructure, and a high demand for advanced therapeutics.